Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
What Is Invasive Breast Cancer? Types, Causes & Treatment.
What Is Invasive Breast Cancer? Types, Causes & Treatment. 4

Getting a diagnosis of invasive breast cancer can be scary. It’s a big health issue worldwide, affecting many people and their families. We want to help you understand your health journey better.

Knowing how this disease works is key to managing it. By learning about the different types, you can help yourself heal. We think knowing more about your health can make you feel better and more confident.

At Liv Hospital, we put our patients first. We make sure you get a full check-up. If you have an nvasive breast cancer diagnosis or need a second opinion, we’re here for you. Our team will support you every step of the way, with care and knowledge.

Key Takeaways

  • Invasive disease needs a plan based on the tumor’s details.
  • Finding cancer early means more treatment options are available.
  • We focus on your health and how you feel, not just your body.
  • Knowing your diagnosis helps you take charge of your health.
  • Getting advice from doctors is key to understanding treatment.

Defining Invasive Breast Cancer

Apr 1451 image 2 LIV Hospital
What Is Invasive Breast Cancer? Types, Causes & Treatment. 5

To give the best care, we need to clearly define invasive breast cancer. This happens when abnormal cells break through their walls. These walls are in places like milk ducts or lobules.

When cells break through, they start to spread into healthy breast tissue. This change is a big step. It means we need to act fast to help.

The Biological Mechanism of Invasion

The growth of invasive breast carcinoma is complex. At first, cells grow in the ducts without spreading.

But over time, they learn to break down the basement membrane. This lets them move into the stroma, the breast’s supportive tissue.

When we talk about breast invasive carcinoma, we mean this ability to move. This is what makes it different from non-invasive conditions.

Current Statistics and Prevalence in the United States

It’s important to know how common invasive adenocarcinoma breast is. We watch these numbers to help our patients the best we can.

For 2025, we expect about 319,750 new cases in the U.S. Many wonder, what is invasive carcinoma of the breast and how does it affect people?

The table below shows the main differences between non-invasive and invasive stages. It helps explain how the disease progresses.

FeatureNon-Invasive (In Situ)Invasive
Cell LocationConfined to ducts/lobulesSpread to surrounding tissue
Risk of SpreadVery lowHigher chance of spreading
Treatment FocusLocal controlBoth local and systemic treatments
Clinical UrgencyPreventativeNeed for quick action

Understanding the Primary Types of Invasive Breast Cancer

Apr 1451 image 3 LIV Hospital
What Is Invasive Breast Cancer? Types, Causes & Treatment. 6

When we talk about breast health, it’s important to know the main types of invasive cancer. Many patients learn about ductal and lobular carcinoma during their first visit. These cancers start in different parts of the breast tissue.

Knowing the difference between ductal carcinoma and lobular carcinoma helps doctors plan your treatment. Both types need quick action, but they grow differently. This knowledge lets us tailor your care to fit your needs.

Invasive Ductal Carcinoma (IDC) Characteristics

Invasive Ductal Carcinoma, or IDC, is the most common type. It makes up about 75 to 80 percent of invasive breast cancer cases. It starts in the cells lining the milk ducts.

When cancer cells break through the duct wall, they spread to the breast tissue. They can then move to other parts of the body. Key features of IDC include:

  • It often feels like a hard, palpable lump during a physical exam.
  • It’s often found through routine mammograms.
  • The cells grow in a solid mass, unlike other types.

Invasive Lobular Carcinoma (ILC) and Its Unique Growth Patterns

Invasive Lobular Carcinoma, or lc medical abbreviation, makes up about 10 to 15 percent of cases. It starts in the milk-producing glands, or lobules. Its growth patterns are different and sometimes hard to spot.

Because these cells grow in single-file strands, they can be tricky to find on standard images. Our specialists use advanced tools for accurate detection. We make sure to evaluate each case carefully.

FeatureInvasive Ductal Carcinoma (IDC)Invasive Lobular Carcinoma (ILC)
OriginMilk DuctsMilk-producing Lobules
Prevalence75-80% of cases10-15% of cases
ComparisonInvasive ductal carcinoma vs invasive lobular carcinomaInvasive lobular carcinoma vs invasive ductal carcinoma
Growth PatternSolid massSingle-file strands
Key ContrastInvasive ductal carcinoma vs lobular carcinomaDuctal vs lobular carcinoma / Lobular vs ductal carcinoma

Causes, Risk Factors, and Diagnostic Approaches

Understanding the causes and how to diagnose breast cancer is key to your health. We want you to know as much as you can about your health. This way, you can make smart choices about your well-being. Knowing about invasive carcinoma breast cancer helps us tailor your screenings to fit your needs.

Identifying Potencial Risk Factors

Many things can lead to breast cancer, from genes to the environment. We can’t change our genes, but we can control our lifestyle choices. Early awareness is the first step in preventing it.

Here are some risk factors we watch for:

  • A personal or family history of breast or ovarian cancer.
  • Genetic mutations, such as those found in the BRCA1 or BRCA2 genes.
  • Getting older, which increases the chance of cell changes.
  • Hormonal factors, like how long you’re exposed to estrogen.

Diagnostic Imaging and Detection Challenges

Different types of breast cancer need different detection methods. For example, carcinoma ductal invasivo is often found as a lump, making mammograms effective. But, ductal carcinoma vs lobular carcinoma is harder to spot on X-rays.

When comparing invasive mammary carcinoma vs invasive ductal carcinoma, we see how they grow. IDC forms a clear mass, but lobular cells grow in lines. This makes them tricky to see on X-rays, sometimes needing MRI.

FeatureIDC (Ductal Invasivo)ILC (Lobular)
Growth PatternForms a solid massSingle-file strands
DetectionEasier via mammogramMore difficult to image
PresentationOften a palpable lumpMay feel like thickening

We use the latest tech to find these cancers. Our team works with you to make sure your screenings are right for you. Your comfort is our top concern at every step.

Conclusion

Getting a breast cancer diagnosis is tough. It’s both a medical challenge and a personal journey. Our team is here to help with care that’s both precise and caring.

We know how hard this is for you. We’re committed to giving you the best care possible. We focus on your unique needs with kindness and skill.

Being informed helps you make better choices for your health. We create treatment plans just for you. This way, every patient gets top-notch care.

Our team is ready to help you. We want to talk about your situation and the options we offer. Your health is our main goal, and we’re here to support you.

FAQ

How do we define invasive breast cancer and its primary characteristics?

Invasive breast cancer refers to cancer that has broken through the normal ducts or lobules of the breast and has begun to spread into surrounding breast tissue. The most common form is Invasive Ductal Carcinoma. “Invasive” means the cancer is no longer confined to its original location and has the potential to spread to lymph nodes or distant organs.

What is the difference between invasive lobular carcinoma vs invasive ductal carcinoma?

Invasive Ductal Carcinoma starts in the milk ducts, which carry milk to the nipple. Invasive Lobular Carcinoma starts in the lobules, which produce milk. Ductal carcinoma is more common and often forms a distinct lump, while lobular carcinoma may spread in a more diffuse pattern, sometimes making it harder to detect on imaging.

What is invasive carcinoma of the breast in terms of diagnostic terminology?

“Invasive carcinoma of the breast” is a general diagnostic term used when cancer cells have spread beyond the ducts or lobules into surrounding tissue, but the specific subtype (such as ductal or lobular) may not yet be fully classified. It is often refined later into more specific diagnoses like Invasive Ductal Carcinoma after pathology review.

Why is it important to distinguish between ductal carcinoma vs lobular carcinoma for treatment?

Distinguishing between subtypes helps guide treatment planning because each behaves differently. Invasive Ductal Carcinoma tends to form localized masses and is often easier to detect early, while Invasive Lobular Carcinoma can spread more subtly through breast tissue. These differences can influence imaging choices, surgical planning, and assessment of spread.

Is there a difference between invasive mammary carcinoma vs invasive ductal carcinoma?

“Invasive mammary carcinoma” is a broader term that generally refers to any invasive breast cancer, including both ductal and lobular types. Invasive Ductal Carcinoma is a specific subtype under this umbrella. In many pathology reports, “mammary carcinoma” is later clarified into a more precise classification.

How common is invasive ductal carcinoma vs invasive lobular carcinoma in the global community?

Invasive Ductal Carcinoma is the most common type, accounting for about 70–80% of invasive breast cancers worldwide. Invasive Lobular Carcinoma is less common, representing roughly 10–15% of cases. The remaining percentage includes rare and mixed subtypes.

 References:

 National Center for Biotechnology Information. https://pubmed.ncbi.nlm.nih.gov/31513398/

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 26 75